5-hydroxytryptamine receptors in the human cardiovascular system.
about
Serotonylation of vascular proteins important to contractionThe use of lorcaserin in the management of obesity: a critical appraisalTrazodone and omeprazole interaction causing frequent second-degree Mobitz type 1 atrioventricular (AV) block (Wenckebach phenomenon) and syncope: a case report and literature reviewModifying ligand-induced and constitutive signaling of the human 5-HT4 receptorRole of endothelial AADC in cardiac synthesis of serotonin and nitrates accumulationOn the presence of serotonin in mammalian cardiomyocytes.PsychedelicsMonoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload.Consensus recommendations for the diagnosis and management of well-differentiated gastroenterohepatic neuroendocrine tumours: a revised statement from a Canadian National Expert Group.Platelet response to serotonin in patients with stable coronary heart diseaseSkeletal effects of serotonin (5-hydroxytryptamine) transporter inhibition: evidence from in vitro and animal-based studies5-hydroxtryptamine receptors in systemic hypertension: an arterial focus.Serotonin receptors and heart valve disease--it was meant 2B.The two faces of serotonin in bone biology.Coronary artery spasm: review and update.The cardiac ventricular 5-HT4 receptor is functional in late foetal development and is reactivated in heart failure.Lorcaserin and adiposopathy: 5-HT2c agonism as a treatment for 'sick fat' and metabolic disease.Investigation of the role of 5-HT2 receptor subtypes in the control of the bladder and the urethra in the anaesthetized female rat.The expanded biology of serotonin.The Pharmacology of TD-8954, a Potent and Selective 5-HT(4) Receptor Agonist with Gastrointestinal Prokinetic Properties.Agents increasing cyclic GMP amplify 5-HT4-elicited positive inotropic response in failing rat cardiac ventricle.Decreased osteoclastogenesis in serotonin-deficient mice.Serotonin and blood pressure regulation.Down-regulation of the serotonin transporter in hyperreactive platelets counteracts the pro-thrombotic effect of serotonin.Serotonin contributes to high pulmonary vascular tone in a sheep model of persistent pulmonary hypertension of the newbornLacidipine has antiatherosclerotic effects independent of its actions on lipid metabolism and blood pressureTreatment with the selective serotonin reuptake inhibitor, fluoxetine, attenuates the fish hypoxia responseLorcaserin for the treatment of obesityOntogenic changes of the control by phosphodiesterase-3 and -4 of 5-HT responses in porcine heart and relevance to human atrial 5-HT(4) receptors.Selective desensitization of the 5-HT4 receptor-mediated response in pig atrium but not in stomach.Role of serotoninergic pathways in drug-induced valvular heart disease and diagnostic features by echocardiographyPKA regulatory subunit 1A inactivating mutation induces serotonin signaling in primary pigmented nodular adrenal disease.Review paper: Current strategies in the development of anti-obesity drugs and their safety concerns.Identification and functional characterisation of 5-HT4 receptor in sea cucumber Apostichopus japonicus (Selenka).The Role of Serotonin beyond the Central Nervous System during EmbryogenesisPlatelets and cardiac arrhythmia.Distinct signaling pathways activated by "extracellular" and "intracellular" serotonin in heart valve development and disease.Peripheral circulation.Cardiac manifestations of gastrointestinal carcinoid tumor.Cardiovascular adverse effects of newer antidepressants.
P2860
Q21562428-E7929B21-8C9E-4ADA-8799-023DF0B0F265Q24594774-9850ADCC-C200-41FA-9A94-4FA20D85739BQ26825569-F9D962C4-60DD-435D-A109-B9E203BAC67FQ28472395-D000E824-40E0-4A69-8C22-0E453A115461Q28481404-42390684-1F65-4157-86AF-DB0F6DAA1CAEQ30318162-73A63084-95A9-4FEB-8A64-CAC6BACEE7E2Q30359998-77B29EE7-0A37-4C50-AAF5-BE9D9F034FE2Q33580858-A772A995-389E-4CCA-8D0D-90331972F0DFQ33894587-DDC11B57-E38C-43D7-8A15-627B386594E4Q34034485-BDF48D6E-B633-4A5F-A2C5-B2C12F4AF6B0Q34140313-48C0FB12-C087-4371-A3F1-328829D5271BQ34145991-9F1D1E4F-11C5-4A5E-A428-E55CDF21D15BQ34173511-C4950B10-293C-47C1-9AE2-74ECDD019BDFQ34191657-3D8CD6F1-28F0-49DB-AD9F-B1187463A309Q34201543-57EDCF56-8F77-4D1F-96E8-586EF0105DB2Q34429191-08FCC26C-FE83-4EE5-BC24-DEFDE1BBF900Q34659424-D143F41D-6111-4269-893D-30F1120BB644Q34792786-D04D18CF-D089-4FAD-9249-0DAA7E910D5EQ34993925-931EEEFA-0CD4-463A-A893-D2E9EBE827F9Q35025872-33931F3F-06B1-4CEF-BC82-2E5B0A8CA91FQ35563508-05440CBF-6A89-495C-BB21-248F5520825EQ35787005-6EBD6C20-EC56-4958-A236-9CE25F4C177DQ35847080-95B41602-41F6-49EE-896D-DD99EC69CE05Q35892630-CE80C137-4D75-47A0-8090-1CB8DD300794Q36923860-AEB75D2B-BC78-48BF-9B26-18F97719DD0EQ36947562-F07653D0-C3C3-4A7C-8AFA-530E3C47FF98Q37157519-8870CA43-48A4-49D7-ABA6-E773AC533723Q37172259-C89BC80B-72A5-4075-A709-112DBAACE682Q37230983-D57F3573-9A43-4865-A4DE-C0FB35B55545Q37231016-A8623883-10F4-496F-B463-B963A0BC544AQ37256634-C06B3F5C-D188-4087-A9AD-2077A4BCE231Q37277025-B1E237BC-0E6C-42DB-BEBA-0E32D53E22F1Q37359377-6299F681-3665-4298-87A6-B9F7708F87BDQ37563446-956BAB92-3707-4D81-82BB-73C21C2D5C81Q37694441-3177A752-13F2-4D97-9B62-26B1A8C602EBQ37855541-C120E9F3-4B72-4E5A-B856-DA303AAC36A4Q38100690-6F7CB3E4-5759-4A15-A782-E33642012F47Q38111280-F85C4025-5EA7-4EF5-9C3E-348D7378C1E4Q38120087-4BABFBCD-402E-48CC-A85C-3CE24E0DF62EQ38205025-EE27F57F-E22C-47C3-8666-C6179BD6A9C8
P2860
5-hydroxytryptamine receptors in the human cardiovascular system.
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
5-hydroxytryptamine receptors in the human cardiovascular system.
@ast
5-hydroxytryptamine receptors in the human cardiovascular system.
@en
5-hydroxytryptamine receptors in the human cardiovascular system.
@nl
type
label
5-hydroxytryptamine receptors in the human cardiovascular system.
@ast
5-hydroxytryptamine receptors in the human cardiovascular system.
@en
5-hydroxytryptamine receptors in the human cardiovascular system.
@nl
prefLabel
5-hydroxytryptamine receptors in the human cardiovascular system.
@ast
5-hydroxytryptamine receptors in the human cardiovascular system.
@en
5-hydroxytryptamine receptors in the human cardiovascular system.
@nl
P1476
5-hydroxytryptamine receptors in the human cardiovascular system.
@en
P2093
Alberto J Kaumann
Finn Olav Levy
P304
P356
10.1016/J.PHARMTHERA.2005.12.004
P577
2006-09-01T00:00:00Z